awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q36406971-3D43C2C1-9D72-48F3-B57D-661F53A5BC3F
Q36406971-3D43C2C1-9D72-48F3-B57D-661F53A5BC3F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36406971-3D43C2C1-9D72-48F3-B57D-661F53A5BC3F
CD30-targeting drugs: cure for mastocytosis?
P2860
Q36406971-3D43C2C1-9D72-48F3-B57D-661F53A5BC3F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36406971-3D43C2C1-9D72-48F3-B57D-661F53A5BC3F
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
85d562a3a105f2c9a483eac7689725d6fffc0cc3
P2860
Brentuximab vedotin demonstrates objective responses in a phase 2 study of relapsed/refractory DLBCL with variable CD30 expression.